Hall 407 ESMO Colloquium
Date
Fri, 22.11.2019
Time
12:45 PM - 02:15 PM
Location
Hall 407
Chairs
  • Marina C. Garassino
  • Ross A. Soo
ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC ESMO Colloquium

Introduction

Lecture Time
12:45 PM - 12:50 PM
Speakers
  • Ross A. Soo
Location
Hall 407, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
12:45 PM - 02:15 PM
Authors
  • Ross A. Soo
ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC ESMO Colloquium

Immune-Check Points Inhibitors (ICI) in non-oncogenic addicted mNSCLC

Lecture Time
12:50 PM - 01:15 PM
Speakers
  • Marina C. Garassino
Location
Hall 407, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
12:45 PM - 02:15 PM
Authors
  • Marina C. Garassino
ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC ESMO Colloquium

EGFR mutant mNSCLC: Single agent or in combination?

Lecture Time
01:15 PM - 01:40 PM
Speakers
  • Fabrice Barlesi
Location
Hall 407, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
12:45 PM - 02:15 PM
Authors
  • Fabrice Barlesi
ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC ESMO Colloquium

Future development for the use of biomarkers

Lecture Time
01:40 PM - 02:05 PM
Speakers
  • Ross A. Soo
Location
Hall 407, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
12:45 PM - 02:15 PM
Authors
  • Ross A. Soo
ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC ESMO Colloquium

Conclusion

Lecture Time
02:05 PM - 02:10 PM
Location
Hall 407, Singapore, Singapore, Singapore
Date
Fri, 22.11.2019
Time
12:45 PM - 02:15 PM